Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma, Published online: 26 March 2018; doi:10.1038/s41416-018-0061-6

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

https://ift.tt/2Gnz62l